Wolverine Trading
MNTA

Wolverine Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Wolverine Trading’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15,336
Closed -$278K – 6284
2018
Q2 		$278K Hold
15,336
– – ﹤0.01% 3900
2018
Q1 		$278K Buy
+15,336
New +$256K ﹤0.01% 3900
2016
Q3 		– Sell
-11,045
Closed -$130K – 5314
2016
Q2 		$117K Buy
+11,045
New +$114K ﹤0.01% 3565

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wolverine Trading's MNTA Position: Q3 2018 in Review

Wolverine Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2018, closing a stake of 15,336 shares — an estimated $278K sold.

Wolverine Trading first reported a position in MNTA in Q2 2016 and held it in 3 quarters. The position peaked at $278K in Q2 2018. 159 funds tracked by Wall St. Rank hold MNTA as of Q3 2018.

  • Wolverine Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Wolverine Trading sold 15,336 Momenta Pharmaceuticals, Inc. shares in Q3 2018, an estimated $278K.
  • Wolverine Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
  • Wolverine Trading's Momenta Pharmaceuticals, Inc. position peaked at $278K in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2018.

Based on Wolverine Trading's 13F filing for Q3 2018, filed 14 Nov 2018.